Remab Therapeutics

remab.jpg

Datos de contacto

Remab Therapeutics
Feixa Llarga S/N, Ed.
Hospitalet de Llobregat
Barcelona
932607355
Áreas de actividad
  • A. Biotecnología Sanitaria
  • A. Biotecnología Sanitaria
  • Áreas terapéuticas
  • A. Biotecnología Sanitaria
  • Áreas terapéuticas
  • Enfermedades infecciosas

RemAb Therapeutics is a biotech company that develops a novel class of medicines.

Productos y servicios

Hospital-acquired infections are a major cause of morbidity, mortality and costs in Intensive care units (ICUs) worldwide. The most critical infectious group consist of Gram-negative bacteria that are resistant to multiple antibiotics.We have developed RA-01, a novel drug product and a first line therapy for preventing infectious diseases at ICUs. Simultaneously we have under research several new indications that will be added to our pipeline soon.